Test of brain testing during stimulant treatment for ADHD
Treatments studied
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This trial checks whether a “NIH Toolbox” set of child-friendly tests can detect changes when stimulant medicine is used for ADHD. It may help doctors better measure how well stimulant treatment is working in people with intellectual disability.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of intellectual disability and an IQ below 80
- Your mental age is at least 3 years old
- You also have a diagnosis of ADHD
- You can take and complete the NIH Toolbox (NIHTB-CB) tests during screening/baseline
- You have not used stimulant medicine within the last 2 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how ADHD stimulant medicine may change disruptive behaviors like aggression, tantrums, or refusing instructions. It may help clinicians understand whether stimulant dosing is supporting both ADHD symptoms and day-to-day behavior.
This trial tests starting a new medication (Methylphenidate or Guanfacine) in young children with moderate or severe ADHD to see how well it works and if it’s safe.
This Phase 4 study checks whether certain markers change in the brain/body when children with ADHD take methylphenidate (a stimulant). It also compares these markers with healthy children to better understand ADHD.
This study tests whether brain wave recordings (EEG) can help predict how well children with ADHD will respond to stimulant medications. It aims to find the best treatment faster, potentially reducing the guesswork in choosing the right medication.
This study tests whether CNS stimulant medications can improve irritability and aggression in children with ADHD. It looks for factors that predict who will benefit most.
This study looks at how the brain's electrical activity may predict whether a child with ADHD will respond well to methylphenidate (Ritalin). It aims to find biological markers that could help doctors choose the right treatment sooner.
Hear when a new Intellectual Disability trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.